Rheumatoid arthritis affects millions, yet finding the right treatment has been difficult because previous research mostly focused on people of European descent. A massive new study changes that by looking at genetic data from the Million Veteran Program, which includes European, East Asian, African American, and Admixed American participants. This approach uses advanced computer tools to automatically spot disease signs in health records, allowing researchers to see patterns that were hidden before.
The team found 152 specific spots in the genome linked to the disease, with 31 of these being completely new discoveries. More importantly, they created a risk score that predicts who might get the disease more accurately than older methods. This new score works best for African American and Admixed American groups, helping doctors understand the disease in people who were previously underrepresented in medical research.
While this is a major step forward, the study did not test any new drugs or treatments. It simply mapped the genetic landscape to help future research. Because the data comes from existing health records, the findings are grounded in real-world veteran experiences rather than a controlled lab setting. This work lays the foundation for better, more personalized care for all patients.
